Antibodies, BispecificAntineoplastic Agents, ImmunologicalB-Cell Maturation Antigen
Dr. Tibor Moskovits, MD
NPI1558362137PAC ID8729040662
- Medicare services, 2024
- 1,494
- Medicare patients, 2024
- 702
- Part D claims, 2024
- 509
- Publications
- 5
- Clinical trials
- 1
- Practice address
- 14 Wall St, New York, NY 10005
- Practice phone
- Call (212) 263-1481
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
NYU Langone Perlmutter Cancer Center - 34th St
New York, New York
Find Dr. Moskovits' professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Tibor Moskovits is a hematologist and oncologist in New York, New York
Dr. Moskovits practices at NYU Langone Perlmutter Cancer Center - 34th St in New York, New York.
Dr. Moskovits' NPI, 1558362137, was assigned on August 9, 2005. Dr. Moskovits graduated from State University of New York Downstate Medical Center College of Medicine in 1985. Dr. Moskovits holds New York license 168880.
NPI and contact details
- NPI
- 1558362137NPI Registry (opens in a new tab)
- Medicare PAC ID
- 8729040662
- NPI enumeration date
- August 9, 2005
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (212) 263-1481
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 67
- Medical school graduation
- 1985
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Tibor Moskovits practices at NYU Langone Perlmutter Cancer Center - 34th St in New York, New York
Dr. Moskovits' primary practice is NYU Langone Perlmutter Cancer Center - 34th St, at 14 Wall St, New York, NY 10005 in New York County. The practice phone is (212) 263-1481.
- NYU Langone Perlmutter Cancer Center - 34th St14 Wall St, New York, NY 10005 · New York CountyPhone(212) 263-1481
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Tibor Moskovits is affiliated with 3 sites of care and 1 medical group
Dr. Moskovits' primary practice is NYU Langone Perlmutter Cancer Center - 34th St in New York, New York. Dr. Moskovits is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Moskovits to 1 more group practice or clinic, named with a free account.
NYU Langone Perlmutter Cancer Center - 34th StPrimary
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Tibor Moskovits' practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Moskovits practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| NYU Langone Perlmutter Cancer Center - 34th St | Available with a free account |
| +2 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Moskovits practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Tibor Moskovits is one of 996 hematologists and oncologists in New York
Hematology and oncology is Dr. Moskovits' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Moskovits is licensed in New York.
Specialties and state licenses
- Hematology and oncology, New YorkPrimary
Hematologists and oncologists near Dr. Moskovits
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Tibor Moskovits billed Medicare for 1,494 services in 2024
CMS data shows 1,494 Medicare services from Dr. Moskovits across 10 procedure codes in 2024, for 702 Medicare patients. Medicare paid $117,743 for them.
Medicare services, 20241,494
Medicare patients702
Paid by Medicare$117,743
Procedure codes10
Dr. Moskovits' Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 1,4022024: 1,4574%
- Surgery
- 2023: 02024: 37
Where Dr. Moskovits' Medicare services took place, 2024
- In an office1,43596%
- In a facility594%
Dr. Moskovits compared with the New York median for hematologists and oncologists, 2024
- Dr. Moskovits
- New York median
- Medicare services
- 1,494vs 6682.2 times
- Medicare patients
- 702vs 2103.3 times
- Part D claims
- 370vs 25843% above
Medians across 940 hematologists and oncologists in New York with Dmand AI profiles that report each measure.
Dr. Moskovits' most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Moskovits?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Moskovits and other hematologists and oncologists in New York.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Tibor Moskovits treated 702 Medicare patients in 2024, average age 77
CMS counts 702 Medicare patients who saw Dr. Moskovits in 2024. The largest group is 75 to 84, with 315 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 14% are also on Medicaid. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Moskovits' median patient age at 72, with 54% women.
Medicare patients, 2024702
Average age77
Average risk score1.59
Also on Medicaid14%
Dr. Moskovits' Medicare patients by age, 2024
Dr. Moskovits' Medicare patients by sex, 2024
- Women41759%
- Men28541%
Chronic conditions among Dr. Moskovits' Medicare patients, 2024
- High cholesterol75%
- High blood pressure71%
- Arthritis56%
- Ischemic heart disease38%
- Osteoporosis34%
- Cancer32%
- Diabetes27%
- Chronic kidney disease25%
Share of Medicare patients with each condition. A patient can have several.
Dr. Moskovits' patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 72
Patient panel by sex, all payers
- Women54%
- Men42%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Tibor Moskovits wrote 509 Medicare Part D claims in 2024
In 2024, Dr. Moskovits wrote 509 Medicare Part D claims for 100 patients. 71% of them were for generic drugs. CMS names the drug for 370 of them, across 11 drugs with 11 or more claims each, at $540,818 in total drug cost. In 2023, CMS named 396 claims across 12 drugs.
Part D claims, 2024509
Drugs named by CMS11
Total drug cost$540,818
Part D patients100
Dr. Moskovits' Part D claims by kind of drug, 2024
- Generic359 claims71%
- Brand-name150 claims29%
Dr. Moskovits' most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Moskovits' Part D claims, 2024
- Antibiotics4%22 of 509 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 3962024: 3707%
Drugs named by CMS: 11 in 2024, 12 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Tibor Moskovits scored 91 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Moskovits for performance year 2024, reported as part of a group. Dr. Moskovits accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Moskovits as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Moskovits' MIPS scores, performance year 2024
- 91of 100Final score
- 91.8of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 75of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Find hematologists and oncologists like Dr. Moskovits by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Tibor Moskovits has 5 publications on record
Dmand AI links 5 papers to Dr. Moskovits, published from 2016 to 2025. Dr. Moskovits' most frequent co-authors are Bruce Raphael, MD, Noa Biran, MD and Jun Han Choi, MD.
Papers5
Years published2016 to 2025
Dr. Moskovits' papers by year, 2016 to 2025
Dr. Moskovits' most frequent co-authors
Recent publications by Dr. Moskovits
Blood Cancer J
Antineoplastic Combined Chemotherapy ProtocolsAntiviral AgentsDisease Progression
Epidural NeoplasmsFluorodeoxyglucose F18Image Processing, Computer-Assisted
See who Dr. Moskovits researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Moskovits works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Tibor Moskovits has worked on 1 clinical trial
Dmand AI links Dr. Moskovits to 1 clinical trial. Conditions studied include Hodgkin Disease and Lymphoma, Non-Hodgkin.
Conditions in Dr. Moskovits' trials
- Hodgkin Disease
- Lymphoma, Non-Hodgkin
Investigators on the most trials with Dr. Moskovits
- Jeffrey A. Barnes, MD, PhD1 shared trial
- Michael L. Grossbard, MD1 shared trial
- Jean Louise Koff, MD1 shared trial
Recent clinical trials with Dr. Moskovits
A Phase I/II Study of the Combination of Pembrolizumab and Lenalidomide, in Patients With Relapsed Non-Hodgkin and Hodgkin Lymphoma (opens in a new tab)
TerminatedPhase 1/2
Hodgkin DiseaseLymphoma, Non-HodgkinLenalidomidePembrolizumab
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Tibor Moskovits received $288 in industry payments from 2017 to 2023
CMS Open Payments shows 4 general payments to Dr. Moskovits from 4 drug and device companies from 2017 to 2023. Food and beverage make up the largest share, 100% of the total. BeiGene, Ltd. paid the most, $125.
General payments to Dr. Moskovits by program year, 2017 to 2023
Companies that paid Dr. Moskovits the most, 2017 to 2023
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Tibor Moskovits graduated from State University of New York Downstate Medical Center College of Medicine
Dr. Moskovits graduated from State University of New York Downstate Medical Center College of Medicine in 1985.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Tibor Moskovits's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Tibor Moskovits
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Tibor Moskovits' NPI number?
Dr. Tibor Moskovits' NPI number is 1558362137. It was assigned on August 9, 2005, and it is active in the NPI Registry.
What kind of doctor is Dr. Tibor Moskovits?
Dr. Tibor Moskovits is a hematologist and oncologist in New York, New York. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Tibor Moskovits practice?
Dr. Moskovits practices at 14 Wall St, New York, NY 10005. Dr. Moskovits' primary practice is NYU Langone Perlmutter Cancer Center - 34th St in New York, New York. Dmand AI also links Dr. Moskovits to 1 group practice or clinic.
What is Dr. Tibor Moskovits' office phone number?
The practice phone on file for Dr. Moskovits is (212) 263-1481.
What is Dr. Tibor Moskovits' medical license number?
Dr. Moskovits holds New York license 168880.
Which hospitals is Dr. Tibor Moskovits affiliated with?
Dr. Moskovits is affiliated with Tisch Hospital.
What medical group is Dr. Tibor Moskovits part of?
Dr. Moskovits is linked to NYU Langone Orthopedic Surgery Associates.
Does Dr. Tibor Moskovits accept Medicare?
Yes. CMS data shows Dr. Moskovits billed Medicare for 1,494 services in 2024, and Dr. Moskovits accepts Medicare assignment.
Does Dr. Tibor Moskovits offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Moskovits as offering telehealth services.
What is Dr. Tibor Moskovits' MIPS score?
Dr. Moskovits' MIPS final score for performance year 2024 is 91 out of 100, reported as part of a group.
Show 8 more questionsShow fewer questions
How many Medicare patients does Dr. Tibor Moskovits see?
CMS counts 702 Medicare patients who saw Dr. Moskovits in 2024, with an average age of 77.
What services does Dr. Tibor Moskovits bill to Medicare?
In 2024, Dr. Moskovits' most billed Medicare services were office visit, established patient (99214), office visit, established patient (99213) and office visit, new patient (99205).
Where did Dr. Tibor Moskovits go to medical school?
Dr. Moskovits graduated from State University of New York Downstate Medical Center College of Medicine in 1985.
What drugs does Dr. Tibor Moskovits prescribe most?
In 2024 Medicare Part D data, Dr. Moskovits' most prescribed drugs by claims were Hydroxyurea, Eliquis and Acyclovir.
Has Dr. Tibor Moskovits received payments from drug or device companies?
CMS Open Payments shows $288 in general payments to Dr. Moskovits from 4 companies from 2017 to 2023. The largest total came from BeiGene, Ltd.
How long has Dr. Tibor Moskovits been practicing?
Dr. Moskovits graduated from medical school in 1985, 41 years ago.
Does Dr. Tibor Moskovits do research?
Dmand AI links 5 publications to Dr. Moskovits, published from 2016 to 2025. Dr. Moskovits has worked on 1 clinical trial.
Who does Dr. Tibor Moskovits publish with?
Dr. Moskovits' most frequent co-authors are Bruce Raphael, MD (2 shared papers), Noa Biran, MD (1 shared paper) and Jun Han Choi, MD (1 shared paper).
Selling to hematology and oncology practices?
See hematologists and oncologists in New York by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card